Guest guest Posted September 5, 2008 Report Posted September 5, 2008 This is from the Dr. Rath Foundation newsletter. Shan Astra's Crestor fails in new heart-failure study AstraZeneca Plc's cholesterol drug Crestor has failed in a second clinical trial for heart failure, suggesting such statin medicines don't improve survival in patients with the chronic condition. Patients given Crestor proved just as likely to die early or be admitted to hospital with cardiovascular problems as those on standard therapy alone, researchers told the European Society of Cardiology annual meeting on Sunday. _Read news report at reuters.com_ (http://www.reuters.com/article/rbssHealthcareNews/idUSLV161720080831) _http://www.reuters.com/article/rbssHealthcareNews/idUSLV161720080831_ (http://www.reuters.com/article/rbssHealthcareNews/idUSLV161720080831) Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.